Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
567 studies found for:    "Growth Hormone"
Show Display Options
Rank Status Study
1 Unknown  Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
Condition: Turner Syndrome
Intervention: Drug: somatotropin
2 Recruiting Albright Hereditary Osteodystrophy: Growth Hormone Trial and Cognitive/Behavioral Assessments
Conditions: Pseudohypoparathyroidism Type 1a;   Albright Hereditary Osteodystrophy
Interventions: Drug: Growth hormone;   Drug: Growth Hormone
3 Suspended American Norditropin Studies - Registry of Growth Hormone (GH) Patients
Condition: Growth Hormone Deficiency
Intervention: Drug: Norditropin Growth Hormone
4 Completed
Has Results
Effect of Short Term Growth Hormone Releasing Hormone in Healthy Men
Condition: Healthy Volunteers
Intervention: Drug: Growth Hormone Releasing Hormone (Tesamorelin)
5 Unknown  Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: growth hormone (Nutropin)
6 Terminated Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
Conditions: Hormone Deficiency;   Aging
Intervention: Drug: Growth Hormone Releasing Hormone (GHRH )
7 Completed
Has Results
Effects of Short-term Growth Hormone in HIV-infected Patients
Condition: HIV Lipodystrophy
Interventions: Drug: Growth hormone;   Drug: Growth Hormone Releasing Hormone
8 Completed Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism
Condition: Hypothyroidism
Interventions: Drug: Growth hormone;   Drug: Growth hormone treatment and puberty
9 Terminated
Has Results
Growth Hormone Therapy for Wasting in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: Nutropin AQ
10 Completed Effects of Growth Hormone Administration on Muscle Strength and Body Composition in Men Over 50 Years Old
Condition: Healthy
Intervention: Drug: growth hormone
11 Unknown  Growth Hormone for Osteoporosis Pseudoglioma Syndrome
Condition: Osteoporosis Pseudoglioma Syndrome
Intervention: Biological: Human recombinant growth hormone
12 Recruiting The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment
Condition: Mild Cognitive Impairment
Intervention: Drug: Growth Hormone Releasing Hormone (GHRH)
13 Withdrawn Low Dose Growth Hormone in Obese PCOS Women
Condition: Polycystic Ovary Syndrome
Intervention: Drug: Nutropin
14 Withdrawn Low Dose Growth Hormone Treatment in Subjects With Metabolic Syndrome.
Condition: Metabolic Syndrome
Intervention: Drug: Norditropin
15 Terminated
Has Results
Clinical Trial of Growth Hormone in MPS I, II, and VI
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis II;   Mucopolysaccharidosis VI
Intervention: Drug: Somatropin (DNA origin)
16 Completed Growth Hormone to Increase Immune Function in People With HIV
Condition: HIV Infections
Intervention: Drug: Somatropin (recombinant human growth hormone)
17 Completed
Has Results
Safety and Efficacy Study of Serostim® Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Condition: Human Immunodeficiency Virus-Associated Adipose Redistribution Syndrome
Intervention: Biological: Serostim
18 Completed
Has Results
Predictive Markers in Chinese Growth Hormone Deficiency (GHD) Children Treated With Saizen®
Condition: Dwarfism, Pituitary
Intervention: Drug: Recombinant human growth hormone (r-hGH)
19 Completed Growth Hormone and Chromosome 18q- and Abnormal Growth
Conditions: Loss of Chromosome 18q;   Growth Hormone Deficiency
Interventions: Drug: Nutropin AQ;   Procedure: Arginine and Clonidine Stimulation Testing;   Procedure: Growth Factors Laboratory Testing;   Procedure: Neuropsychological Testing
20 Completed Antagonist Protocol in Poor Responders
Condition: Female Infertility Due to Diminished Ovarian Reserve
Intervention: Drug: Growth Hormone

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.